Delivery Order SPE2DR25D2101-SPE2DR26F49DD
Award Date 3/11/26
Potential Completion Date 3/12/26
Potential Value $20K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $14,587.88 delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for Actemra 400 mg/20 mL vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC held by parent company Cencora, Inc., valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of March 12, 2026.</p>
- <p>The Defense Logistics Agency issued a $17,081 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Actemra 400 mg/20 mL vials under a firm fixed-price arrangement. The order was issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 global pharmaceutical supply vehicle running through December 2026.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is March 5, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $2,026.20 delivery order to AmerisourceBergen Drug Corp on February 25, 2026, for supply of Actemra 80 mg/4 mL vials.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 26, 2026.</p>
- The Defense Logistics Agency issued a $12,709.81 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for ACTEMRA 162 mg/0.9 mL syringes, with an ultimate completion date of March 2, 2026. The order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of...
- The Defense Logistics Agency issued a $6,586.10 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Actemra 162 mg/0.9 mL syringes under a firm fixed-price arrangement. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides pharmaceutical and medical supplies to military healthcare systems globally. Place of performance is Conshohocken, PA. The ultimate completion date is March...
- The Defense Logistics Agency issued a $3,884.56 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for ACTEMRA 162 mg/0.9 mL syringes under a firm fixed-price arrangement. The order will be completed by March 9, 2026. Place of performance is Conshohocken, PA. The delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999 and running through December 2026....
- <p>The Defense Logistics Agency issued a $3,448.46 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Actemra 162 mg/0.9 mL syringes. The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2031) and carries a firm fixed price. Place of performance is Conshohocken, PA. Ultimate completion date is March 10, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a $5,957.71 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999.00 and extending through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order carries firm...
- <p>The Defense Logistics Agency issued a $3,010.67 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Actemra 162 mg/0.9 mL syringes.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 9, 2026.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product, with a ceiling value of $15,746.54. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides global pharmaceutical support to military healthcare systems. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F49DDDelivery Order
The Defense Logistics Agency issued a $20,155.32 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for ACTEMRA 400 mg/20 ml vials. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of March 12, 2026. No set-aside was used.
Generated 6/9/26, 10:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 3/10/26 |